MARTEK BIOSCIENCES CORP
DelistedCIK 892025fmd_07E4HFJVK40YB975Q14P9CZY2ZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Nov 01, 2007 to Oct 31, 2010, 5 periods
Latest annual · FY2010
Millions- Total revenues
- 450
- Gross profit
- 217
- Operating income
- 51
- Net income
- 28
Latest quarter · Q4 FY2010
Millions- Total revenues
- 119
- Gross profit
- 62
- Operating income
- (8)
- Net income
- (6)
- Free cash flow
- 40
MARTEK BIOSCIENCES CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2010 | FY2009 | Change | Source |
|---|---|---|---|---|
| Revenue | $450 million | $345.2 million | +30.4% | 10-K 2010-12-29 · proof |
| Gross profit | $216.8 million | $148.6 million | +45.9% | 10-K 2010-12-29 · proof |
| Operating income | $50.8 million | $63.6 million | -20.1% | 10-K 2010-12-29 · proof |
| Net income | $27.9 million | $40.6 million | -31.3% | 10-K 2010-12-29 · proof |
| Total assets | $798.8 million | $689.8 million | +15.8% | 10-K 2010-12-29 · proof |
| Total liabilities | $127.8 million | $53.7 million | +138.1% | 10-K 2010-12-29 · proof |
| Cash and cash equivalents | $63.7 million | $141.1 million | -54.8% | 10-K 2010-12-29 · proof |
| Total debt | $7.1 million | $810,000 | +773.2% | 10-K 2010-12-29 · proof |
- What was MARTEK BIOSCIENCES CORP's revenue in fiscal 2010?
- MARTEK BIOSCIENCES CORP reported revenue of $450 million for fiscal 2010 (the year ended Oct 31, 2010), against $345.2 million the year before (+30.4%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What was MARTEK BIOSCIENCES CORP's gross profit in fiscal 2010?
- MARTEK BIOSCIENCES CORP reported gross profit of $216.8 million for fiscal 2010 (the year ended Oct 31, 2010), against $148.6 million the year before (+45.9%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What was MARTEK BIOSCIENCES CORP's operating income in fiscal 2010?
- MARTEK BIOSCIENCES CORP reported operating income of $50.8 million for fiscal 2010 (the year ended Oct 31, 2010), against $63.6 million the year before (-20.1%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What was MARTEK BIOSCIENCES CORP's net income in fiscal 2010?
- MARTEK BIOSCIENCES CORP reported net income of $27.9 million for fiscal 2010 (the year ended Oct 31, 2010), against $40.6 million the year before (-31.3%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What are MARTEK BIOSCIENCES CORP's total assets?
- As of Oct 31, 2010, MARTEK BIOSCIENCES CORP reported total assets of $798.8 million, against $689.8 million a year earlier (+15.8%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What are MARTEK BIOSCIENCES CORP's total liabilities?
- As of Oct 31, 2010, MARTEK BIOSCIENCES CORP reported total liabilities of $127.8 million, against $53.7 million a year earlier (+138.1%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What are MARTEK BIOSCIENCES CORP's cash and cash equivalents?
- As of Oct 31, 2010, MARTEK BIOSCIENCES CORP reported cash and cash equivalents of $63.7 million, against $141.1 million a year earlier (-54.8%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
- What is MARTEK BIOSCIENCES CORP's total debt?
- As of Oct 31, 2010, MARTEK BIOSCIENCES CORP reported total debt of $7.1 million, against $810,000 a year earlier (+773.2%). Source: the 10-K filed with the SEC on Dec 29, 2010. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:892025&period_type=annual&limit=5"Information only, not investment advice.